Demetrix
PrivateLast Round
Series A
Jul 11, 2019
Total Funding Raised
$61M
Company Overview
Demetrix is a biotechnology company that developed a fermentation system to produce natural medicines and rare cannabinoids through genetics and computing-enabled technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Demetrix Comparables
Compare Demetrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creo | 90% | |
| Hyasynth Biologicals Inc. | 90% | |
| Biomedican | 87% | |
Demetrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 11, 2019 | ||||
| Seed | Sep 6, 2017 |
Demetrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Seed |
| Tuatara Capital | Series A |
| Berkeley Catalyst Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 11, 2019
$50M round led by Tuatara Capital
- Sep 6, 2017
$11M round led by Horizons Ventures.
Demetrix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Demetrix's valuation, stock price, and market status.